These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
866 related articles for article (PubMed ID: 33175236)
1. Molecular basis for drug repurposing to study the interface of the S protein in SARS-CoV-2 and human ACE2 through docking, characterization, and molecular dynamics for natural drug candidates. Alazmi M; Motwalli O J Mol Model; 2020 Nov; 26(12):338. PubMed ID: 33175236 [TBL] [Abstract][Full Text] [Related]
2. Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using Choudhary S; Malik YS; Tomar S Front Immunol; 2020; 11():1664. PubMed ID: 32754161 [TBL] [Abstract][Full Text] [Related]
3. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection. Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306 [TBL] [Abstract][Full Text] [Related]
4. Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2). Guo X; Chen Z; Xia Y; Lin W; Li H J Transl Med; 2020 Aug; 18(1):321. PubMed ID: 32831104 [TBL] [Abstract][Full Text] [Related]
5. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites. Qiao B; Olvera de la Cruz M ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067 [TBL] [Abstract][Full Text] [Related]
6. Dynamics of the ACE2-SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms. Ali A; Vijayan R Sci Rep; 2020 Aug; 10(1):14214. PubMed ID: 32848162 [TBL] [Abstract][Full Text] [Related]
7. An integrated drug repurposing strategy for the rapid identification of potential SARS-CoV-2 viral inhibitors. Trezza A; Iovinelli D; Santucci A; Prischi F; Spiga O Sci Rep; 2020 Aug; 10(1):13866. PubMed ID: 32807895 [TBL] [Abstract][Full Text] [Related]
8. Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2. Basu A; Sarkar A; Maulik U Sci Rep; 2020 Oct; 10(1):17699. PubMed ID: 33077836 [TBL] [Abstract][Full Text] [Related]
9. Structural and functional modelling of SARS-CoV-2 entry in animal models. Brooke GN; Prischi F Sci Rep; 2020 Sep; 10(1):15917. PubMed ID: 32985513 [TBL] [Abstract][Full Text] [Related]
10. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. Liu Z; Xiao X; Wei X; Li J; Yang J; Tan H; Zhu J; Zhang Q; Wu J; Liu L J Med Virol; 2020 Jun; 92(6):595-601. PubMed ID: 32100877 [TBL] [Abstract][Full Text] [Related]
11. A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor. Souza PFN; Lopes FES; Amaral JL; Freitas CDT; Oliveira JTA Int J Biol Macromol; 2020 Dec; 164():66-76. PubMed ID: 32693122 [TBL] [Abstract][Full Text] [Related]
12. Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2. Verkhivker G Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158276 [TBL] [Abstract][Full Text] [Related]
13. Hot spot profiles of SARS-CoV-2 and human ACE2 receptor protein protein interaction obtained by density functional tight binding fragment molecular orbital method. Lim H; Baek A; Kim J; Kim MS; Liu J; Nam KY; Yoon J; No KT Sci Rep; 2020 Oct; 10(1):16862. PubMed ID: 33033344 [TBL] [Abstract][Full Text] [Related]
14. Scaffold morphing of arbidol (umifenovir) in search of multi-targeting therapy halting the interaction of SARS-CoV-2 with ACE2 and other proteases involved in COVID-19. Choudhary S; Silakari O Virus Res; 2020 Nov; 289():198146. PubMed ID: 32866534 [TBL] [Abstract][Full Text] [Related]
16. Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex. Laurini E; Marson D; Aulic S; Fermeglia M; Pricl S ACS Nano; 2020 Sep; 14(9):11821-11830. PubMed ID: 32833435 [TBL] [Abstract][Full Text] [Related]
17. Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19. Fu J; Zhou B; Zhang L; Balaji KS; Wei C; Liu X; Chen H; Peng J; Fu J Mol Biol Rep; 2020 Jun; 47(6):4383-4392. PubMed ID: 32410141 [TBL] [Abstract][Full Text] [Related]
18. Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor. Yang J; Petitjean SJL; Koehler M; Zhang Q; Dumitru AC; Chen W; Derclaye S; Vincent SP; Soumillion P; Alsteens D Nat Commun; 2020 Sep; 11(1):4541. PubMed ID: 32917884 [TBL] [Abstract][Full Text] [Related]
19. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).]. Lvov DK; Alkhovsky SV Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561 [TBL] [Abstract][Full Text] [Related]
20. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart. Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]